ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States. The company invests in commercial real estate credit investments, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and CRE equity investments. It qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.

ACRES Commercial Realty Corp.

An announcement from Acrux ( ($AU:ACR) ) is now available. Acrux Ltd, a company listed on the ASX, has announced a change in the director’s interes...

Acrux Ltd Director Increases Shareholding

The latest announcement is out from Acrux ( ($AU:ACR) ). Acrux Limited has announced the quotation of 1,345,002 ordinary fully paid securities on t...

Acrux Limited Announces Quotation of New Securities on ASX

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intellia Therapeutics (NTLA – Research Report) and...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and Acrivon Therapeutics, Inc. (ACRV)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Acrivon Therapeutics, Inc. (ACRV – Research Report...

Analysts Conflicted on These Healthcare Names: Acrivon Therapeutics, Inc. (ACRV) and Bristol-Myers Squibb (BMY)

In a report released today, Donald Fandetti from Wells Fargo maintained a Sell rating on Ares Commercial, with a price target of $4.00. According t...

Wells Fargo Keeps Their Sell Rating on Ares Commercial (ACRE)

KWG Resources ( ($TSE:CACR) ) has shared an announcement. The Canadian Chrome Company Inc. has observed heightened trading activity in its shares b...

Canadian Chrome Company Updates on Trading Activity and Corporate Developments

Ares Commercial Real Estate ( ($ACRE) ) has released its Q3 earnings. Here is a breakdown of the information Ares Commercial Real Estate presented ...

Ares Commercial Real Estate Reports Q3 2025 Earnings

As we move into the final stretch of the year, stocks continue to grind higher, with the S&P 500 now up 16% year-to-date. Once again, it’s Big Tech...

Analysts Predict Up to 550% Rally for These 2 ‘Strong Buy’ Penny Stocks

Kepler Capital analyst Julien Richer maintained a Hold rating on Accor SA on October 24 and set a price target of €48.00. The company’s shares clos...

Current Quarter	$NA	Next Quarter	$NA
Current Year	$NA	Next Year	$NA
QoQ Growth	NaN%	YoY Growth	NaN%
3Y EPS CAGR	N/A	Target Price	$24.50
Consensus	Buy	Upside	+19.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACR	$20.43	+3.29%	392.58K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACR	$20.43	+3.3%	392.58K
3
4
5
6

ACR

ACR

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get ACRES Commercial Realty Corp. Data in Excel

Get ACRES Commercial Realty Corp. Data in Excel